Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
We work very hard (sometimes biting off more than we can chew as a company) but it is a very rewarding place to work.
O que você mais gosta nos lideres?
Honesty, passion, determination, innovative, hard-working
Qual é a melhor parte das suas compensações?
stock incentives, salary, bonus, benefits
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
results-oriented, company keeps patients-first, innovative-thinking,
O que faz você mais feliz no trabalho?
Seeing the impact we are having on patients' lives
Other Employee Reviews for Karyopharm Therapeutics
×